Add to ORKGon dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherap
In the UK, prostate cancer is the second most commonly occurring cancer in men. The number of prosta...
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate...
AAPM TG43 dose calculation formalism in breast interstitial high-dose-rate brachytherapy with the us...
Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fra...
High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cance
Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resona...
Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brac...
Catheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of pros...
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspectiv
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate...
Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prosta...
Purpose: To review and analyze the published data on high-dose-rate brachytherapy as monotherapy in ...
Cancer incidence and mortality depend on a number of factors, including age, socio-economic status a...
A number of clinical trials are investigating the role of prostate focal brachytherapy as an alterna...
is an effective treatment option among radiation therapies. Permanent prostate brachytherapy using 1...
In the UK, prostate cancer is the second most commonly occurring cancer in men. The number of prosta...
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate...
AAPM TG43 dose calculation formalism in breast interstitial high-dose-rate brachytherapy with the us...
Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fra...
High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cance
Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resona...
Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brac...
Catheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of pros...
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspectiv
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate...
Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prosta...
Purpose: To review and analyze the published data on high-dose-rate brachytherapy as monotherapy in ...
Cancer incidence and mortality depend on a number of factors, including age, socio-economic status a...
A number of clinical trials are investigating the role of prostate focal brachytherapy as an alterna...
is an effective treatment option among radiation therapies. Permanent prostate brachytherapy using 1...
In the UK, prostate cancer is the second most commonly occurring cancer in men. The number of prosta...
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate...
AAPM TG43 dose calculation formalism in breast interstitial high-dose-rate brachytherapy with the us...